These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19850448)

  • 21. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.
    Nag D; Garg RK; Agarwal A
    J Assoc Physicians India; 1998 Feb; 46(2):185-8. PubMed ID: 11273108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.
    Sachdeo R; Beydoun A; Schachter S; Vazquez B; Schaul N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2001 Sep; 57(5):864-71. PubMed ID: 11552018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine.
    Clemens B; Ménes A; Nagy Z
    Acta Neurol Scand; 2004 May; 109(5):324-9. PubMed ID: 15080858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxcarbazepine in infants and young children with partial seizures.
    Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
    Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy.
    Franzoni E; Gentile V; Pellicciari A; Garone C; Iero L; Gualandi S; Cordelli DM; Cecconi I; Moscano FC; Marchiani V; Errani A
    J Neurol; 2009 Sep; 256(9):1527-32. PubMed ID: 19597919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
    Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
    El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
    Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxcarbazepine (Trileptal). An effective and well tolerated new drug as first choice in treatment of focal seizures].
    Schmidt D; Elger CE
    Nervenarzt; 2000 Oct; 71(10):849-55. PubMed ID: 11082818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How is oxcarbazepine different from carbamazpine?].
    Schmidt D; Elger CE
    Nervenarzt; 2004 Feb; 75(2):153-60. PubMed ID: 14770287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers.
    Antunes NJ; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Marques MP; Lanchote VL
    J Pharm Biomed Anal; 2018 Feb; 149():442-447. PubMed ID: 29169112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
    Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
    Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10-Hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs.
    Armijo JA; Vega-Gil N; Shushtarian M; Adín J; Herranz JL
    Ther Drug Monit; 2005 Apr; 27(2):199-204. PubMed ID: 15795652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
    Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL
    Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy].
    Balogh A; Szentesi A; Jánosi I
    Ideggyogy Sz; 2010 Nov; 63(11-12):385-95. PubMed ID: 21413440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.